Catheter ablation for cardiac arrhythmias: a 14-year experience with 5330 consecutive patients at the Quebec Heart Institute, Laval Hospital.
BACKGROUND
Catheter ablation is a curative treatment with excellent success and minimal complication rates for patients with supraventricular or ventricular arrhythmias.


METHODS
The acute outcomes and complications of all catheter ablation procedures for supraventricular and ventricular arrhythmias performed at the Quebec Heart Institute (Sainte-Foy, Quebec) during a 14-year period from January 1, 1993, to December 31, 2006, were prospectively assessed. The ablation procedures were classified according to the arrhythmias induced using standard electrophysiological techniques and definitions. Immediate success and complication rates were prospectively included in the database.


RESULTS
A total of 5330 patients had catheter ablation performed at the Institute during the period assessed. The mean (+/- SD) age of patients was 50 +/- 18 years (range four to 97 years), and 2340 patients (44%) were men. Most of the patients were younger than 75 years (group 1), and 487 (9%) were 75 years of age and older (group 2). Indications for ablations were as follows: atrioventricular nodal re-entry tachycardia (AVNRT) in 2263 patients, accessory pathways in 1147 patients, atrioventricular node ablation in 803 patients, typical atrial flutter in 377 patients and atrial tachycardia in 160 patients; 580 patients had other ablation procedures. The overall success rates were 81% for atrial tachycardia, 92% for accessory pathways or flutter, and 99% for AVNRT or atrioventricular node ablation. There was no difference in the success rates of the younger (group 1) and older (group 2) patients. Seventy-seven patients (1.4%) had complications, including 11 major events (myocardial infarction in one patient, pulmonary embolism in three patients and permanent pacemaker in seven patients). In patients undergoing AVNRT ablation, two had a permanent pacemaker implanted immediately after the procedure and three had a permanent pacemaker implanted at follow-up.


CONCLUSIONS
The results confirm that radiofrequency ablation is safe and effective, supporting ablation therapy as a first-line therapy for the majority of patients with cardiac arrhythmias.
O'Hara
Gilles E
GE
Institut Universitaire de Cardiologie et de Pneumologie, Hopital Laval, Sainte-Foy, Quebec. Gilles.ohara@med.ulaval.ca
Philippon
François
F
Champagne
Jean
J
Blier
Louis
L
Molin
Franck
F
Côté
Jean-Marc
JM
Nault
Isabelle
I
Sarrazin
Jean-François
JF
Gilbert
Marcel
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001145:Arrhythmias, Cardiac / Q000628:therapy*; D001282:Atrial Flutter / Q000628:therapy; D017115:Catheter Ablation; D002648:Child; D002675:Child, Preschool; D004594:Electrophysiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011792:Quebec; D013611:Tachycardia, Atrioventricular Nodal Reentry / Q000628:therapy; D013612:Tachycardia, Ectopic Atrial / Q000628:therapy; D013617:Tachycardia, Supraventricular / Q000628:therapy; D017180:Tachycardia, Ventricular / Q000628:therapy; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000628:therapy; D055815:Young Adult